Astrid Marijke van der Sar

Astrid Marijke van der Sar

Auto-generated profile, based on publicly available information

Astrid Marijke van der Sar

Department of Medical Microbiology and Infection Control, Free University Medical Center , 1081 BT Amsterdam

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2003 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
ASAstrid M. Van Der Sar
Astrid M. Van Der Sar
RMRené J. P. Musters
René J. P. Musters
FEFredericus J. M. Van Eeden
Fredericus J. M. Van Eeden
BABen J. Appelmelk
Ben J. Appelmelk
CVChristina M. J. E. Vandenbroucke-Grauls
Christina M. J. E. Vandenbroucke-Grauls
WBWilbert Bitter
Wilbert Bitter
Bacterial virulence is best studied in animal models. However, the lack of possibilities for real time analysis and the need for laborious and invasive sample analysis limit the use of experimental a...

15 March 2012 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
EBErica L. Benard
Erica L. Benard
ASAstrid M. van der Sar
Astrid M. van der Sar
FEFelix Ellett
Felix Ellett
GLGraham Lieschke
Graham Lieschke
Herman SpainkHerman Spaink
Herman Spaink
Annemarie MeijerAnnemarie Meijer
Annemarie Meijer
Zebrafish (Danio rerio) embryos are increasingly used as a model for studying the function of the vertebrate innate immune system in host-pathogen interactions 1. The major cell types of the innate immune system, macrophages and neutrophils, develop during the first days of embryogenesis prior to the maturation of lymphocytes that are required for adaptive immune responses. The ease of obtaining large numbers of embryos, their accessibility due to external development, the optical transparency of embryonic and larval stages, a wide range of genetic tools, extensive mutant resources and collections of transgenic reporter lines, all add to the versatility of the zebrafish model. Salmonella enterica serovar Typhimurium (S. typhimurium) and Mycobacterium marinum can reside intracellularly in macrophages and are frequently used to study host-pathogen interactions in zebrafish embryos. The infection processes of these two bacterial pathogens are interesting to compare because S. typhimurium infection is acute and lethal within one day, whereas M. marinum infection is chronic and can be imaged up to the larval stage 2, 3. The site of micro-injection of bacteria into the embryo (Figure 1) determines whether the infection will rapidly become systemic or will initially remain localized. A rapid systemic infection can be established by micro-injecting bacteria directly into the blood circulation via the caudal vein at the posterior blood island or via the Duct of Cuvier, a wide circulation channel on the yolk sac connecting the heart to the trunk vasculature. At 1 dpf, when embryos at this stage have phagocytically active macrophages but neutrophils have not yet matured, injecting into the blood island is preferred. For injections at 2-3 dpf, when embryos also have developed functional (myeloperoxidase-producing) neutrophils, the Duct of Cuvier is preferred as the injection site. To study directed migration of myeloid cells towards local infections, bacteria can be injected into the tail muscle, otic vesicle, or hindbrain ventricle 4-6. In addition, the notochord, a structure that appears to be normally inaccessible to myeloid cells, is highly susceptible to local infection 7. A useful alternative for high-throughput applications is the injection of bacteria into the yolk of embryos within the first hours after fertilization 8. Combining fluorescent bacteria and transgenic zebrafish lines with fluorescent macrophages or neutrophils creates ideal circumstances for multi-color imaging of host-pathogen interactions. This video article will describe detailed protocols for intravenous and local infection of zebrafish embryos with S. typhimurium or M. marinum bacteria and for subsequent fluorescence imaging of the interaction with cells of the innate immune system.

1 October 2004 in Trends in Microbiology
Verified
Journal Article
Closed access
ASAstrid M. van der Sar
Astrid M. van der Sar
BABen J. Appelmelk
Ben J. Appelmelk
CVChristina M.J.E. Vandenbroucke-Grauls
Christina M.J.E. Vandenbroucke-Grauls
WBWilbert Bitter
Wilbert Bitter

1 November 2011 in The Journal of Immunology
Verified
Journal Article
Closed access
AAAbdallah Musa Abdallah
Abdallah Musa Abdallah
JBJovanka Bestebroer
Jovanka Bestebroer
NSNigel D L Savage
Nigel D L Savage
KPKarin de Punder
Karin de Punder
MZMaaike van Zon
Maaike van Zon
PPPeter J Peters
Peter J Peters
During infection of humans and animals, pathogenic mycobacteria manipulate the host cell causing severe diseases such as tuberculosis and leprosy. To understand the basis of mycobacterial pathogenicity, it is crucial to identify the molecular virulence mechanisms. In this study, we address the contribution of ESX-1 and ESX-5—two homologous type VII secretion systems of mycobacteria that secrete distinct sets of immune modulators—during the macrophage infection cycle. Using wild-type, ESX-1– and ESX-5–deficient mycobacterial strains, we demonstrate that these secretion systems differentially affect subcellular localization and macrophage cell responses. We show that in contrast to ESX-1, the effector proteins secreted by ESX-5 are not required for the translocation of Mycobacterium tuberculosis or Mycobacterium marinum to the cytosol of host cells. However, the M. marinum ESX-5 mutant does not induce inflammasome activation and IL-1β activation. The ESX-5 system also induces a caspase-independent cell death after translocation has taken place. Importantly, by means of inhibitory agents and small interfering RNA experiments, we reveal that cathepsin B is involved in both the induction of cell death and inflammasome activation upon infection with wild-type mycobacteria. These results reveal distinct roles for two different type VII secretion systems during infection and shed light on how virulent mycobacteria manipulate the host cell in various ways to replicate and spread.

1 April 2006 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
ASAstrid M. van der Sar
Astrid M. van der Sar
OSOliver W. Stockhammer
Oliver W. Stockhammer
CLCarina van der Laan
Carina van der Laan
Herman SpainkHerman Spaink
Herman Spaink
WBWilbert Bitter
Wilbert Bitter
Annemarie MeijerAnnemarie Meijer
Annemarie Meijer
Innate immunity signaling mechanisms during vertebrate embryogenesis are largely unknown. To study Toll-like receptor (TLR) signaling function in the zebrafish embryo model, we designed an experimental setup for antisense morpholino knockdown under conditions of bacterial infection. Clearance of Salmonella enterica serovar Typhimurium Ra bacteria was significantly impaired after knockdown of myeloid differentiation factor 88 (MyD88), a common adaptor protein in TLR and interleukin-1 receptor signaling. Thereby, we demonstrate for the first time that the innate immune response of the developing embryo involves MyD88-dependent signaling, which further establishes the zebrafish embryo as a model for the study of vertebrate innate immunity.

1 January 2009 in The International Journal of Developmental Biology
Verified
Journal Article
Open access
PDF file
SBSebastiaan A. Brittijn
Sebastiaan A. Brittijn
SDSuzanne J. Duivesteijn
Suzanne J. Duivesteijn
MBMounia Belmamoune
Mounia Belmamoune
LBLaura F.M. Bertens
Laura F.M. Bertens
WBWilbert Bitter
Wilbert Bitter
michael richardsonmichael richardson
michael richardson
Basic research in pattern formation is concerned with the generation of phenotypes and tissues. It can therefore lead to new tools for medical research. These include phenotypic screening assays, applications in tissue engineering, as well as general advances in biomedical knowledge. Our aim here is to discuss this emerging field with special reference to tools based on zebrafish developmental biology. We describe phenotypic screening assays being developed in our own and other labs. Our assays involve: (i) systemic or local administration of a test compound or drug to zebrafish in vivo; (ii) the subsequent detection or "readout" of a defined phenotypic change. A positive readout may result from binding of the test compound to a molecular target involved in a developmental pathway. We present preliminary data on assays for compounds that modulate skeletal patterning, bone turnover, immune responses, inflammation and early-life stress. The assays use live zebrafish embryos and larvae as well as adult fish undergoing caudal fin regeneration. We describe proof-of-concept studies on the localised targeting of compounds into regeneration blastemas using microcarriers. Zebrafish are cheaper to maintain than rodents, produce large numbers of transparent eggs, and some zebrafish assays could be scaled-up into medium and high throughput screens. However, advances in automation and imaging are required. Zebrafish cannot replace mammalian models in the drug development pipeline. Nevertheless, they can provide a cost-effective bridge between cell-based assays and mammalian whole-organism models.